Quantifying Hepatic Mitochondrial Fluxes in Humans
Status:
Recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
In this study the investigators will quantitate hepatic mitochondrial fluxes in T2D patients
with NAFL and NASH before and after 16-weeks treatment with the insulin sensitizer
pioglitazone
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio